Cancer Drug Prices Slashed by Up to 96.45%; Officials Inspect Agartala Cancer Hospital Pharmacy

Khorang 24-Live
2 Min Read

Agartala: In a major relief for cancer patients and their families, prices of several anti-cancer medicines have been reduced by up to 96.45 per cent following the Central Government’s price-control measures. In this connection, officials conducted an inspection at the pharmacy of Agartala Cancer Hospital to examine the implementation of the revised medicine prices and ensure that patients receive the benefits.

The price reduction is part of the Trade Margin Rationalisation (TMR) initiative introduced by the National Pharmaceutical Pricing Authority (NPPA), under which trade margins on 137 specified anti-cancer medicines have been regulated to make essential cancer drugs more affordable.

According to the revised pricing measures, reductions have been reported across hundreds of anti-cancer medicine formulations, with some brands witnessing price cuts exceeding 50 per cent. The highest reported reduction stands at approximately 96.45 per cent.

The initiative is expected to provide substantial financial relief to patients undergoing cancer treatment, particularly those who require expensive medicines over an extended period. The government estimates that the revised pricing measures could generate annual savings of approximately ₹3,540 crore for consumers across the country.

During the inspection at Agartala Cancer Hospital’s pharmacy, officials focused on the implementation of the revised prices and compliance with the government’s pricing directions. Such inspections are aimed at ensuring transparency in medicine pricing and preventing patients from being charged above the revised maximum retail prices (MRPs).

The NPPA’s initiative is intended to curb excessive trade margins in the pharmaceutical supply chain and improve the affordability of cancer medicines.

The development is being viewed as an important step towards reducing the financial burden on cancer patients, many of whom face significant treatment expenses. However, the actual benefit will depend on the availability of the affected medicines and proper implementation of the revised prices at pharmacies and hospitals.

Share This Article
Leave a Comment

Leave a Reply

Your email address will not be published. Required fields are marked *